Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging

Industrial and Engineering Chemistry Research

Volumn 56, Issue 20, 2017, Pages 5761-5777

  Anderson, Caleb F ^a   Cui, Honggang ^a,b,c  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; NANOSTRUCTURED MATERIALS;

CANCER THERAPEUTICS; DESIGN PRINCIPLES; RECENT TRENDS; RESPONSIVE MATERIALS;

DISEASES;

EID: 85020756751     PISSN: 08885885     EISSN: 15205045     Source Type: Journal    
DOI: 10.1021/acs.iecr.7b00990     Document Type: Review

References (125)

1. Torchilin, V. P. Multifunctional, Stimuli-Senstive Nanoparticle Systems for Drug Delivery Nat. Rev. Drug Discovery 2014, 13, 813-827 10.1038/nrd4333
2. Keliher, E. J.; Reiner, T.; Earley, S.; Klubnick, J.; Tassa, C.; Lee, A. J.; Ramaswamy, S.; Bardeesy, N.; Hanahan, D.; Depinho, R. A.; Castro, C. M.; Weissleder, R. Targeting Cathepsin E in Pancreatic Cancer by a Small Molecule Allows In Vivo Detection Neoplasia 2013, 15, 684-693 10.1593/neo.13276
3. De La Rica, R.; Aili, D.; Stevens, M. M. Enzyme-Responsive Nanoparticles for Drug Release and Diagnostics Adv. Drug Delivery Rev. 2012, 64, 967-978 10.1016/j.addr.2012.01.002
4. Hu, Q.; Katti, P. S.; Gu, Z. Enzyme-Responsive Nanomaterials for Controlled Drug Delivery Nanoscale 2014, 6, 12273-12286 10.1039/C4NR04249B
5. Sun, X.; Li, Y.; Liu, T.; Li, Z.; Zhang, X.; Chen, X. Peptide-Based Imaging Agents for Cancer Detection Adv. Drug Delivery Rev. 2016, 10.1016/j.addr.2016.06.007
6. Liu, T. W. B.; Chen, J.; Zheng, G. Peptide-Based Molecular Beacons for Cancer Imaging and Therapy Amino Acids 2011, 41, 1123-113 10.1007/s00726-010-0499-1
7. Duffy, M. J. The Role of Proteolytic Enzymes in Cancer Invasion and Metastasis Clin. Exp. Metastasis 1992, 10, 145-155 10.1007/BF00132746
8. Chen, S.; Cui, J.; Jiang, T.; Olson, E. S.; Cai, Q.-Y.; Yang, M.; Wu, W.; Guthrie, J. M.; Robertson, J.; Lipton, S. A.; Ma, L.; Tsien, R. Y.; Gu, Z. Gelatinase Activity Imaged by Activatable Cell-Penetrating Peptides in Cell-Based and in Vivo Models of Stroke J. Cereb. Blood Flow Metab. 2015, 37, 1-13
9. Nejadnik, H.; Ye, D.; Lenkov, O. D.; Donig, J. S.; Martin, J. E.; Castillo, R.; Derugin, N.; Sennino, B.; Rao, J.; Daldrup-Link, H. Magnetic Resonance Imaging of Stem Cell Apoptosis in Arthritic Joints with a Caspase Activatable Contrast Agent ACS Nano 2015, 9, 1150-1160 10.1021/nn504494c
10. Maeda, H. The Enhanced Permeability and Retention (EPR) Effect in Tumor Vasculature: The Key Role of Tumor-Selective Macromolecular Drug Targeting Adv. Enzyme Regul. 2001, 41, 189-207 10.1016/S0065-2571(00)00013-3
11. Wang, Y.; Zhou, K.; Huang, G.; Hensley, C.; Huang, X.; Ma, X.; Zhao, T.; Sumer, B. D.; Deberardinis, R. J.; Gao, J. A Nanoparticle-Based Strategy for the Imaging of a Broad Range of Tumours by Nonlinear Amplification of Microenvironment Signals Nat. Mater. 2014, 13, 204-212 10.1038/nmat3819
12. Lee, H.; Akers, W.; Bhushan, K.; Bloch, S.; Sudlow, G.; Tang, R.; Achilefu, S. Near-Infrared pH-Activatable Fluorescent Probes for Imaging Primary and Metastatic Breast Tumors Bioconjugate Chem. 2011, 22, 777-784 10.1021/bc100584d
13. Ji, T.; Zhao, Y.; Wang, J.; Zheng, X.; Tian, Y.; Zhao, Y.; Nie, G. Tumor Fibroblast Specific Activation of a Hybrid Ferritin Nanocage-Based Optical Probe for Tumor Microenvironment Imaging Small 2013, 9, 2427-2431 10.1002/smll.201300600
14. Wang, Y.; Cheetham, A. G.; Angacian, G.; Su, H.; Xie, L.; Cui, H. Peptide-drug Conjugates as Effective Prodrug Strategies for Targeted Delivery Adv. Drug Delivery Rev. 2016, 10.1016/j.addr.2016.06.015
15. Cheetham, A. G.; Zhang, P.; Lin, Y.-A.; Lock, L. L.; Cui, H. Supramolecular Nanostructures Formed by Anticancer Drug Assembly J. Am. Chem. Soc. 2013, 135, 2907-2910 10.1021/ja3115983
16. Chen, B.; Dai, W.; He, B.; Zhang, H.; Wang, X.; Wang, Y.; Zhang, Q. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment Theranostics 2017, 7, 538-558 10.7150/thno.16684
17. Lu, Y.; Sun, W.; Gu, Z. Stimuli-Responsive Nanomaterials for Therapeutic Protein Delivery J. Controlled Release 2014, 194, 1-19 10.1016/j.jconrel.2014.08.015
18. Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-Responsive Nanocarriers for Drug Delivery Nat. Mater. 2013, 12, 991-1003 10.1038/nmat3776
19. Young Choi, K.; Swierczewska, M.; Lee, S.; Chen, X. Protease-Activated Drug Development Theranostics 2012, 2, 156-178 10.7150/thno.4068
20. Bremer, C.; Tung, C.-H.; Bogdanov, A.; Weissleder, R. Imaging of Differential Protease Expression in Breast Cancers for Detection of Aggressive Tumor Phenotypes Radiology 2002, 222, 814-818 10.1148/radiol.2223010812
21. Huang, P.; Gao, Y.; Lin, J.; Hu, H.; Liao, H.-S.; Yan, X.; Tang, Y.; Jin, A.; Song, J.; Niu, G.; Zhang, G.; Horkay, F.; Chen, X. Tumor-Specific Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer Theranostics ACS Nano 2015, 9, 9517-9527 10.1021/acsnano.5b03874
22. Blum, G.; Von Degenfeld, G.; Merchant, M. J.; Blau, H. M.; Bogyo, M. Noninvasive Optical Imaging of Cysteine Protease Activity Using Fluorescently Quenched Activity-Based Probes Nat. Chem. Biol. 2007, 3, 668-677 10.1038/nchembio.2007.26
23. Joyce, J. A.; Baruch, A.; Chehade, K.; Meyer-Morse, N.; Giraudo, E.; Tsai, F.-Y.; Greenbaum, D. C.; Hager, J. H.; Bogyo, M.; Hanahan, D. Cathepsin Cysteine Proteases Are Effectors of Invasive Growth and Angiogenesis during Multistage Tumorigenesis Cancer Cell 2004, 5, 443-453 10.1016/S1535-6108(04)00111-4
24. Gialeli, C.; Theocharis, A. D.; Karamanos, N. K. Roles of Matrix Metalloproteinases in Cancer Progression and Their Pharmacological Targeting FEBS J. 2011, 278, 16-27 10.1111/j.1742-4658.2010.07919.x
25. Vartak, D. G.; Gemeinhart, R. A. Matrix Metalloproteases: Underutilized Targets for Drug Delivery J. Drug Target. 2007, 15, 1-20 10.1080/10611860600968967
26. Lopez-Otin, C.; Matrisian, L. M. Emerging Roles of Proteases in Tumour Suppression Nat. Rev. Cancer 2007, 7, 800-808 10.1038/nrc2228
27. Ahmed, N.; Fessi, H.; Elaissari, A. Theranostic Applications of Nanoparticles in Cancer Drug Discovery Today 2012, 17, 928-934 10.1016/j.drudis.2012.03.010
28. Kelkar, S. S.; Reineke, T. M. Theranostics: Combining Imaging and Therapy Bioconjugate Chem. 2011, 22, 1879-1903 10.1021/bc200151q
29. Torchilin, V. P. Recent Advances with Liposomes as Pharmaceutical Carriers Nat. Rev. Drug Discovery 2005, 4, 145-160 10.1038/nrd1632
30. Baker, J. R. Dendrimer-Based Nanoparticles for Cancer Therapy Hematology 2009, 14, 708-719 10.1182/asheducation-2009.1.708
31. Chen, W.; Ayala-Orozco, C.; Biswal, N. C.; Perez-Torres, C.; Bartels, M.; Bardhan, R.; Stinnet, G.; Liu, X.-D.; Ji, B.; Deorukhkar, A.; Brown, L. V.; Guha, S.; Pautler, R. G.; Krishnan, S.; Halas, N. J.; Joshi, A. Targeting of Pancreatic Cancer with Magneto-Fluorescent Theranostic Gold Nanoshells Nanomedicine (London, U. K.) 2014, 9, 1209-1222 10.2217/nnm.13.84
32. Rosi, N. L.; Mirkin, C. A. Nanostructures in Biodiagnostics Chem. Rev. 2005, 105, 1547-1562 10.1021/cr030067f
33. Sun, T.; Zhang, Y. S.; Pang, B.; Hyun, D. C.; Yang, M.; Xia, Y. Engineered Nanoparticles for Drug Delivery in Cancer Therapy Angew. Chemie-Int. Ed. 2014, 53, 12320-12364 10.1002/anie.201403036
34. Kuang, Y.; Shi, J.; Li, J.; Yuan, D.; Alberti, K. A.; Xu, Q.; Xu, B. Pericellular Hydrogel/nanonets Inhibit Cancer Cells Angew. Chem., Int. Ed. 2014, 53, 8104-8107 10.1002/anie.201402216
35. Zhao, F.; Lung Ma, M.; Xu, B. Molecular Hydrogels of Therapeutic Agents Chem. Soc. Rev. 2009, 38, 883-891 10.1039/B806410P
36. Chau, Y.; Luo, Y.; Cheung, A. C. Y.; Nagai, Y.; Zhang, S.; Kobler, J. B.; Zeitels, S. M.; Langer, R. Incorporation of a Matrix Metalloproteinase-Sensitive Substrate into Self-Assembling Peptides-A Model for Biofunctional Scaffolds Biomaterials 2008, 29, 1713-1719 10.1016/j.biomaterials.2007.11.046
37. Carter, P. J.; Senter, P. D. Antibody-Drug Conjugates for Cancer Therapy Cancer J. 2008, 14, 154-169 10.1097/PPO.0b013e318172d704
38. Zhang, L.; Chan, J. M.; Gu, F. X.; Rhee, J. W.; Wang, A. Z.; Radovic-Moreno, A. F.; Alexis, F.; Langer, R.; Farokhzad, O. C. Self-Assembled Lipid-Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform ACS Nano 2008, 2, 1696-1702 10.1021/nn800275r
39. Cheng, J.; Teply, B. A.; Sherifi, I.; Sung, J.; Luther, G.; Gu, F. X.; Levy-Nissenbaum, E.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Formulation of Functionalized PLGA-PEG Nanoparticles for in Vivo Targeted Drug Delivery Biomaterials 2007, 28, 869-876 10.1016/j.biomaterials.2006.09.047
40. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760 10.1038/nnano.2007.387
41. Choi, H. S.; Liu, W.; Liu, F.; Nasr, K.; Misra, P.; Bawendi, M. G.; Frangioni, J. V. Design Considerations for Tumour-Targeted Nanoparticles Nat. Nanotechnol. 2010, 5, 42-47 10.1038/nnano.2009.314
42. Lee, D.-E.; Koo, H.; Sun, I.-C.; Hee Ryu, J.; Kim, K.; Chan Kwon, I. Multifunctional Nanoparticles for Multimodal Imaging and Theragnosis Chem. Soc. Rev. 2012, 41, 2656-2672 10.1039/c2cs15261d
43. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D. E. Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery Nat. Nanotechnol. 2007, 2, 249-255 10.1038/nnano.2007.70
44. Ma, W.; Cheetham, A. G.; Cui, H. Building Nanostructures with Drugs Nano Today 2015, 11, 13-30 10.1016/j.nantod.2015.11.003
45. Wagh, A.; Singh, J.; Qian, S.; Law, B. A Short Circulating Peptide Nanofiber as a Carrier for Tumoral Delivery Nanomedicine 2013, 9, 449-457 10.1016/j.nano.2012.10.009
46. Yu, M. K.; Park, J.; Jon, S.; Sangyong, J. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy Theranostics 2012, 2, 3-44 10.7150/thno.3463
47. Su, H.; Koo, J. M.; Cui, H. One-Component Nanomedicine J. Controlled Release 2015, 219, 383-395 10.1016/j.jconrel.2015.09.056
48. Gao, Y.; Shi, J.; Yuan, D.; Xu, B. Imaging Enzyme-Triggered Self-Assembly of Small Molecules inside Live Cells Nat. Commun. 2012, 1, 1033-1038 10.1038/ncomms2040
49. Razgulin, A.; Ma, N.; Rao, J. Strategies for in Vivo Imaging of Enzyme Activity: An Overview and Recent Advances Chem. Soc. Rev. 2011, 40, 4186-4216 10.1039/c1cs15035a
50. Cai, Y.; Shi, Y.; Wang, H.; Wang, J.; Ding, D.; Wang, L.; Yang, Z. Environment-Sensitive Fluorescent Supramolecular Nanofibers for Imaging Applications Anal. Chem. 2014, 86, 2193-2199 10.1021/ac4038653
51. Tung, C.; Mahmood, U.; Bredow, S.; Weissleder, R. In Vivo Imaging of Proteolytic Enzyme Activity Using a Novel Molecular Reporter In Vivo Imaging of Proteolytic Enzyme Activity Using a Novel Molecular Reporter 1 Cancer Res. 2000, 60, 4953-4958
52. Weissleder, R.; Tung, C.-H.; Mahmood, U.; Bogdanov, A. In Vivo Imaging of Tumors with Protease-Activated near-Infrared Fluorescent Probes Nat. Biotechnol. 1999, 17, 375-378 10.1038/7933
53. Weissleder, R.; Pittet, M. J. Imaging in the Era of Molecular Oncology Nature 2008, 452, 580-589 10.1038/nature06917
54. Willmann, J. K.; van Bruggen, N.; Dinkelborg, L. M.; Gambhir, S. S. Molecular Imaging in Drug Development Nat. Rev. Drug Discovery 2008, 7, 591-607 10.1038/nrd2290
55. Zhang, P.; Cheetham, A. G.; Lock, L. L.; Li, Y.; Cui, H. Activatable Nanoprobes for Biomolecular Detection Curr. Opin. Biotechnol. 2015, 34, 171-179 10.1016/j.copbio.2015.01.009
56. Liu, S.; Zhang, P.; Banerjee, S. R.; Xu, J.; Pomper, M. G.; Cui, H. Design and Assembly of Supramolecular Dual-Modality Nanoprobes Nanoscale 2015, 7, 9462-9466 10.1039/C5NR01518A
57. Ryu, J. H.; Koo, H.; Sun, I.-C.; Yuk, S. H.; Choi, K.; Kim, K.; Kwon, I. C. Tumor-Trageting Multi-Functional Nanoparticles for Theragnosis: New Paradigm for Cancer Therapy Adv. Drug Delivery Rev. 2012, 64, 1447-1458 10.1016/j.addr.2012.06.012
58. Cheng, Z.; Al Zaki, A.; Hui, J. Z.; Muzykantov, V. R.; Tsourkas, A. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities Science 2012, 338, 903-910 10.1126/science.1226338
59. Janib, S. M.; Moses, A. S.; Mackay, J. A. Imaging and Drug Delivery Using Theranostic Nanoparticles Adv. Drug Delivery Rev. 2010, 62, 1052-1063 10.1016/j.addr.2010.08.004
60. Lammers, T.; Aime, S.; Hennink, W. E.; Storm, G.; Kiessling, F. Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 1029-1038 10.1021/ar200019c
61. Terreno, E.; Uggeri, F.; Aime, S. Image Guided Therapy: The Advent of Theranostic Agents J. Controlled Release 2012, 161, 328-337 10.1016/j.jconrel.2012.05.028
62. Mura, S.; Couvreur, P. Nanotheranostics for Personalized Medicine Adv. Drug Delivery Rev. 2012, 64, 1394-1416 10.1016/j.addr.2012.06.006
63. Jiang, T.; Mo, R.; Bellotti, A.; Zhou, J.; Gu, Z. Gel-Liposome-Mediated Co-Delivery of Anticancer Membrane-Associated Proteins and Small-Molecule Drugs for Enhanced Therapeutic Efficacy Adv. Funct. Mater. 2014, 24, 2295-2304 10.1002/adfm.201303222
64. Langer, R.; Weissleder, R. Nanotechnology JAMA 2015, 313, 135-136 10.1001/jama.2014.16315
65. Li, S.-D.; Huang, L. Pharmacokinetics and Biodistribution of Nanoparticles Mol. Pharmaceutics 2008, 5, 496-504 10.1021/mp800049w
66. Albright, C. F.; Graciani, N.; Han, W.; Yue, E.; Stein, R.; Lai, Z.; Diamond, M.; Dowling, R.; Grimminger, L.; Zhang, S.-Y.; Behrens, D.; Musselman, A.; Bruckner, R.; Zhang, M.; Jiang, X.; Hu, D.; Higley, A.; Dimeo, S.; Rafalski, M.; Mandlekar, S.; Car, B.; Yeleswaram, S.; Stern, A.; Copeland, R. a; Combs, A.; Seitz, S. P.; Trainor, G. L.; Taub, R.; Huang, P.; Oliff, A. Matrix Metalloproteinase-Activated Doxorubicin Prodrugs Inhibit HT1080 Xenograft Growth Better than Doxorubicin with Less Toxicity Mol. Cancer Ther. 2005, 4, 751-760 10.1158/1535-7163.MCT-05-0006
67. Chen, Z.; Zhang, P.; Cheetham, A. G.; Moon, J. H.; Moxley, J. W.; Lin, Y.-A.; Cui, H. Controlled Release of Free Doxorubicin from Peptide-drug Conjugates by Drug Loading J. Controlled Release 2014, 191, 123-130 10.1016/j.jconrel.2014.05.051
68. Veiman, K.-L.; Künnapuu, K.; Lehto, T.; Kiisholts, K.; Pärn, K.; Langel, Ü.; Kurrikoff, K. PEG Shielded MMP Sensitive CPPs for Efficient and Tumor Specific Gene Delivery in Vivo J. Controlled Release 2015, 209, 238-247 10.1016/j.jconrel.2015.04.038
69. Zhu, L.; Wang, T.; Perche, F.; Taigind, A.; Torchilin, V. P. Enhanced Anticancer Activity of Nanopreparation Containing an MMP2-Sensitive PEG-Drug Conjugate and Cell-Penetrating Moiety Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 17047-17052 10.1073/pnas.1304987110
70. Andreasen, P. A.; Kjoller, L.; Christensen, L.; Duffy, M. J. The Urokinasetype Plasminogen Activator System in Cancer Metastasis Int. J. Cancer 1997, 72, 1-22 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z
71. Basel, M. T.; Shrestha, T. B.; Troyer, D. L.; Bossmann, S. H. Protease-Sensitive, Polymer-Caged Liposomes: A Method for Making Highly Targeted Liposomes Using Triggered Release ACS Nano 2011, 5, 2162-2175 10.1021/nn103362n
72. Cheng, Y.-J.; Luo, G.-F.; Zhu, J.-Y.; Xu, X.-D.; Zeng, X.; Cheng, D.-B.; Li, Y.-M.; Wu, Y.; Zhang, X.-Z.; Zhuo, R.-X.; He, F. Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles ACS Appl. Mater. Interfaces 2015, 7, 9078-9087 10.1021/acsami.5b00752
73. Huang, S.; Shao, K.; Kuang, Y.; Liu, Y.; Li, J.; An, S.; Guo, Y.; Ma, H.; He, X.; Jiang, C. Tumor Targeting and Microenvironment-Responsive Nanoparticles for Gene Delivery Biomaterials 2013, 34, 5294-5302 10.1016/j.biomaterials.2013.03.043
74. Kulkarni, P. S.; Haldar, M. K.; Nahire, R. R.; Katti, P.; Ambre, A. H.; Muhonen, W. W.; Shabb, J. B.; Padi, S. K. R.; Singh, R. K.; Borowicz, P. P.; Shrivastava, D. K.; Katti, K. S.; Reindl, K.; Guo, B.; Mallik, S. MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer Mol. Pharmaceutics 2014, 11, 2390-2399 10.1021/mp500108p
75. Tanaka, A.; Fukuoka, Y.; Morimoto, Y.; Honjo, T.; Koda, D.; Goto, M.; Maruyama, T. Cancer Cell Death Induced by the Intracellular Self-Assembly of an Enzyme-Responsive Supramolecular Gelator J. Am. Chem. Soc. 2015, 137, 770-775 10.1021/ja510156v
76. Yang, B. Z.; Gu, H.; Fu, D.; Gao, P.; Lam, J. K.; Xu, B. Enzymatic Formation of Supramolecular Hydrogels Adv. Mater. 2004, 16, 1440-1444 10.1002/adma.200400340
77. Gao, Y.; Kuang, Y.; Guo, Z.-F.; Guo, Z.; Krauss, I. J.; Xu, B. Enzyme-Instructed Molecular Self-Assembly Confers Nanofibers and a Supramolecular Hydrogel of Taxol Derivative J. Am. Chem. Soc. 2009, 131, 13576-13577 10.1021/ja904411z
78. Zhou, J.; Du, X.; Yamagata, N.; Xu, B. Enzyme-Instructed Self-Assembly of Small D-Peptides as a Multiple- Step Process for Selectively Killing Cancer Cells J. Am. Chem. Soc. 2016, 138, 3813-3823 10.1021/jacs.5b13541
79. Wang, H.; Feng, Z.; Wang, Y.; Zhou, R.; Yang, Z.; Xu, B. Integrating Enzymatic Self-Assembly and Mitochondria Targeting for Selectively Killing Cancer Cells without Acquired Drug Resistance J. Am. Chem. Soc. 2016, 138, 16046-16055 10.1021/jacs.6b09783
80. Kalafatovic, D.; Nobis, M.; Javid, N.; Frederix, P. W. J. M.; Anderson, K. I.; Saunders, B. R.; Ulijn, R. V. MMP-9 Triggered Micelle-to-Fibre Transitions for Slow Release of Doxorubicin Biomater. Sci. 2015, 3, 246-249 10.1039/C4BM00297K
81. Kalafatovic, D.; Nobis, M.; Son, J.; Anderson, K. I.; Ulijn, R. V. MMP-9 Triggered Self-Assembly of Doxorubicin Nanofiber Depots Halts Tumor Growth Biomaterials 2016, 98, 192-202 10.1016/j.biomaterials.2016.04.039
82. Tung, C.-H.; Bredow, S.; Mahmood, U.; Weissleder, R. Preparation of a Cathepsin D Sensitive Near-Infrared Fluorescence Probe for Imaging Bioconjugate Chem. 1999, 10, 892-896 10.1021/bc990052h
83. Medintz, I. L.; Clapp, A. R.; Brunel, F. M.; Tiefenbrunn, T.; Tetsuo Uyeda, H.; Chang, E. L.; Deschamps, J. R.; Dawson, P. E.; Mattoussi, H. Proteolytic Activity Monitored by Fluorescence Resonance Energy Transfer through Quantum-Dot-peptide Conjugates Nat. Mater. 2006, 5, 581-589 10.1038/nmat1676
84. Burgess, L.; Chen, J.; Wolter, N. E.; Wilson, B.; Zheng, G.; Ramanujam, N.; Mitchell, M. F.; Mahadevan, A.; Warren, S.; Thomsen, S.; Silva, E.; Richards-Kortum, R.; Lam, S.; Kennedy, T.; Unger, M.; Miller, Y. E.; Gelmont, D.; Rusch, V.; Gipe, B.; Howard, D.; LeRiche, J. C.; Coldman, A.; Gazdar, A. F.; Jayaprakash, V.; Sullivan, M.; Merzianu, M.; Rigual, N. R.; Loree, T. R.; Popat, S. R.; Moysich, K. B.; Ramananda, S.; Johnson, T.; Marshall, J. R.; Hutson, A. D.; Mang, T. S.; Wilson, B. C.; Gill, S. R.; Frustino, J.; Bogaards, A.; Reid, M. E.; Poh, C. F.; Ng, S. P.; Williams, P. M.; Zhang, L.; Laronde, D. M.; Lane, P.; Macaulay, C. Topical MMP Beacon Enabled Fluorescence- Guided Resection of Oral Carcinoma Opt. Soc. Am. 2016, 7, 1089-1099
85. Chi, C.; Du, Y.; Ye, J.; Kou, D.; Qiu, J.; Wang, J.; Tian, J.; Chen, X. Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology Theranostics 2014, 4, 1072-1084 10.7150/thno.9899
86. Kim, K.; Lee, M.; Park, H.; Kim, J.-H.; Kim, S.; Chung, H.; Choi, K.; Kim, I.-S.; Seong, B. L.; Kwon, I. C. Cell-Permeable and Biocompatible Polymeric Nanoparticles for Apoptosis Imaging J. Am. Chem. Soc. 2006, 128, 3490-3491 10.1021/ja057712f
87. Lee, S.; Cha, E.-J.; Park, K.; Lee, S.-Y.; Hong, J.-K.; Sun, I.-C.; Kim, S. Y.; Choi, K.; Kwon, I. C.; Kim, K.; Ahn, C.-H. A Near-Infrared-Fluorescence-Quenched Gold-Nanoparticle Imaging Probe for In Vivo Drug Screening and Protease Activity Determination Angew. Chem. 2008, 120, 2846-2849 10.1002/ange.200705240
88. Matsuo, K.; Kamada, R.; Mizusawa, K.; Imai, H.; Takayama, Y.; Narazaki, M.; Matsuda, T.; Takaoka, Y.; Hamachi, I. Specific Detection and Imaging of Enzyme Activity by Signal-Amplifiable Self-Assembling (19)F MRI Probes Chem.-Eur. J. 2013, 19, 12875-12883 10.1002/chem.201300817
89. Yang, K.; Zhu, L.; Nie, L.; Sun, X.; Cheng, L.; Wu, C.; Niu, G.; Chen, X.; Liu, Z. Visualization of Protease Activity In Vivo Using an Activatable Photo-Acoustic Imaging Probe Based on CuS Nanoparticles Theranostics 2014, 4, 134-141 10.7150/thno.7217
90. Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor Imaging by Means of Proteolytic Activation of Cell-Penetrating Peptides Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 17867-17872 10.1073/pnas.0408191101
91. Dubikovskaya, E. A.; Thorne, S. H.; Pillow, T. H.; Contag, C. H.; Wender, P. A. Overcoming Multidrug Resistance of Small-Molecule Therapeutics through Conjugation with Releasable Octaarginine Transporters Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 12128-12133 10.1073/pnas.0805374105
92. Shapira, A.; Livney, Y. D.; Broxterman, H. J.; Assaraf, Y. G. Nanomedicine for Targeted Cancer Therapy: Towards the Overcoming of Drug Resistance Drug Resist. Updates 2011, 14, 150-163 10.1016/j.drup.2011.01.003
93. Olson, E. S.; Aguilera, T. A.; Jiang, T.; Scadeng, M.; Nguyen, Q. T.; Ellies, L. G.; Tsien, R. Y. In Vivo Characterization of Activatable Cell Penetrating Peptides for Targeting Protease Activity in Cancer Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 4317-4322 10.1073/pnas.0910261107
94. Olson, E. S.; Jiang, T.; Aguilera, T. A.; Nguyen, Q. T.; Ellies, L. G.; Scadeng, M.; Tsien, R. Y. Activatable Cell Penetrating Peptides Linked to Nanoparticles as Dual Probes for in Vivo Fluorescence and MR Imaging of Proteases Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 4311-4316 10.1073/pnas.0910283107
95. Whitney, M.; Savariar, E. N.; Friedman, B.; Levin, R. A.; Crisp, J. L.; Glasgow, H. L.; Lefkowitz, R.; Adams, S. R.; Steinbach, P.; Nashi, N.; Nguyen, Q. T.; Tsien, R. Y. Ratiometric Activatable Cell-Penetrating Peptides Provide Rapid in Vivo Readout of Thrombin Activation Angew. Chem., Int. Ed. 2013, 52, 325-330 10.1002/anie.201205721
96. Hua, N.; Baik, F.; Pham, T.; Phinikaridou, A.; Giordano, N.; Friedman, B.; Whitney, M.; Nguyen, Q. T.; Tsien, R. Y.; Hamilton, J. A. Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis PLoS One 2015, 10, e0139833 10.1371/journal.pone.0139833
97. Crisp, J. L.; Savariar, E. N.; Glasgow, H. L.; Ellies, L. G.; Whitney, M. A.; Tsien, R. Y. Dual Targeting of Integrin a v B 3 and Matrix Metalloproteinase- 2 for Optical Imaging of Tumors and Chemotherapeutic Delivery Mol. Cancer Ther. 2014, 13, 1514-1525 10.1158/1535-7163.MCT-13-1067
98. Blum, G.; Mullins, S. R.; Keren, K.; Fonovič, M.; Jedeszko, C.; Rice, M. J.; Sloane, B. F.; Bogyo, M. Dynamic Imaging of Protease Activity with Fluorescently Quenched Activity-Based Probes Nat. Chem. Biol. 2005, 1, 203-209 10.1038/nchembio728
99. Whitley, M. J.; Cardona, D. M.; Lazarides, A. L.; Spasojevic, I.; Ferrer, J. M.; Cahill, J.; Lee, C.-L.; Snuderl, M.; Blazer, D. G.; Hwang, E. S.; Greenup, R. A.; Mosca, P. J.; Mito, J. K.; Cuneo, K. C.; Larrier, N. A.; O'Reilly, E. K.; Riedel, R. F.; Eward, W. C.; Strasfeld, D. B.; Fukumura, D.; Jain, R. K.; Lee, W. D.; Griffith, L. G.; Bawendi, M. G.; Kirsch, D. G.; Brigman, B. E. A Mouse-Human Phase 1 Co-Clinical Trial of a Protease-Activated Fluorescent Probe for Imaging Cancer Sci. Transl. Med. 2016, 8, 320ra4 10.1126/scitranslmed.aad0293
100. Lock, L. L.; Cheetham, A. G.; Zhang, P.; Cui, H. Design and Construction of Supramolecular Nanobeacons for Enzyme Detection ACS Nano 2013, 7, 4924-4932 10.1021/nn400218a
101. Lock, L. L.; Reyes, C. D.; Zhang, P.; Cui, H. Tuning Cellular Uptake of Molecular Probes by Rational Design of Their Assembly into Supramolecular Nanoprobes J. Am. Chem. Soc. 2016, 138, 3533-3540 10.1021/jacs.6b00073
102. Yang, L.; Peng, X.-H.; Wang, Y. A.; Wang, X.; Cao, Z.; Ni, C.; Karna, P.; Zhang, X.; Wood, W. C.; Gao, X.; Nie, S.; Mao, H. Receptor-Targeted Nanoparticles for In Vivo Imaging of Breast Cancer Clin. Cancer Res. 2009, 15, 4722-4732 10.1158/1078-0432.CCR-08-3289
103. Law, B.; Weissleder, R.; Tung, C.-H. Protease-Sensitive Fluorescent Nanofibers Bioconjugate Chem. 2007, 18, 1701-1704 10.1021/bc070054z
104. Malik, R.; Qian, S.; Law, B. Design and Synthesis of a near-Infrared Fluorescent Nanofiber Precursor for Detecting Cell-Secreted Urokinase Activity Anal. Biochem. 2011, 412, 26-33 10.1016/j.ab.2011.01.010
105. Lowe, S. B.; Dick, J. A. G.; Cohen, B. E.; Stevens, M. M. Multiplex Sensing of Protease and Kinase Enzyme Activity via Orthogonal Coupling of Quantum Dot-Peptide Conjugates ACS Nano 2012, 6, 851-857 10.1021/nn204361s
106. Ye, D.; Shuhendler, A. J.; Cui, L.; Tong, L.; Tee, S. S.; Tikhomirov, G.; Felsher, D. W.; Rao, J. Bioorthogonal Cyclization-Mediated in Situ Self-Assembly of Small-Molecule Probes for Imaging Caspase Activity in Vivo Nat. Chem. 2014, 6, 519-526 10.1038/nchem.1920
107. Ye, D.; Shuhendler, A. J.; Pandit, P.; Brewer, K. D.; Tee, S. S.; Cui, L.; Tikhomirov, G.; Rutt, B.; Rao, J. Caspase-Responsive Smart Gadolinium-Based Contrast Agent for Magnetic Resonance Imaging of Drug-Induced Apoptosis Chem. Sci. 2014, 5, 3845-3852 10.1039/C4SC01392A
108. Palner, M.; Shen, B.; Jeon, J.; Lin, J.; Chin, F. T.; Rao, J. Preclinical Kinetic Analysis of the Caspase-3/7 PET Tracer 18F-C-SNAT: Quantifying the Changes in Blood Flow and Tumor Retention After Chemotherapy J. Nucl. Med. 2015, 56, 1415-1421 10.2967/jnumed.115.155259
109. Witney, T. H.; Hoehne, A.; Reeves, R. E.; Ilovich, O.; Namavari, M.; Shen, B.; Chin, F. T.; Rao, J.; Gambhir, S. S. A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment Clin. Cancer Res. 2015, 21, 3896-3905 10.1158/1078-0432.CCR-14-3176
110. Nejadnik, H.; Ye, D.; Lenkov, O. D.; Donig, J. S.; Martin, J. E.; Castillo, R.; Derugin, N.; Sennino, B.; Rao, J.; Daldrup-Link, H. Magnetic Resonance Imaging of Stem Cell Apoptosis in Arthritic Joints with a Caspase Activatable Contrast Agent ACS Nano 2015, 9, 1150-1160 10.1021/nn504494c
111. Gao, W.; Xiang, B.; Meng, T.; Liu, F.; Qi, X. Chemotherapeutic Drug Delivery to Cancer Cells Using a Combination of Folate Targeting and Tumor Microenvironment-Sensitive Polypeptides Biomaterials 2013, 34, 4137-4149 10.1016/j.biomaterials.2013.02.014
112. Yu, H.; Chen, J.; Liu, S.; Lu, Q.; He, J.; Zhou, Z.; Hu, Y. Enzyme Sensitive, Surface Engineered Nanoparticles for Enhanced Delivery of Camptothecin J. Controlled Release 2015, 216, 111-120 10.1016/j.jconrel.2015.08.021
113. Ruan, S.; Cao, X.; Cun, X.; Hu, G.; Zhou, Y.; Zhang, Y.; Lu, L.; He, Q.; Gao, H. Matrix Metalloproteinase-Sensitive Size-Shrinkable Nanoparticles for Deep Tumor Penetration and pH Triggered Doxorubicin Release Biomaterials 2015, 60, 100-110 10.1016/j.biomaterials.2015.05.006
114. Zhong, J.; Li, L.; Zhu, X.; Guan, S.; Yang, Q.; Zhou, Z.; Zhang, Z.; Huang, Y. A Smart Polymeric Platform for Multistage Nucleus-Targeted Anticancer Drug Delivery Biomaterials 2015, 65, 43-55 10.1016/j.biomaterials.2015.06.042
115. Ku, T.-H.; Chien, M.-P.; Thompson, M. P.; Sinkovits, R. S.; Olson, N. H.; Baker, T. S.; Gianneschi, N. C. Controlling and Switching the Morphology of Micellar Nanoparticles with Enzymes J. Am. Chem. Soc. 2011, 133, 8392-8395 10.1021/ja2004736
116. Stefflova, K.; Chen, J.; Marotta, D.; Li, H.; Zheng, G. Photodynamic Therapy Agent with a Built-In Apoptosis Sensor for Evaluating Its Own Therapeutic Outcome in Situ J. Med. Chem. 2006, 49, 3850-3856 10.1021/jm060146u
117. Stefflova, K.; Chen, J.; Li, H.; Zheng, G. Targeted Photodynamic Therapy Agent with a Built-In Apoptosis Sensor for In Vivo Near-Infrared Imaging of Tumor Apoptosis Triggered by Its Photosensitization In Situ Mol. Imaging 2006, 5, 520-532
118. Zheng, G.; Chen, J.; Stefflova, K.; Jarvi, M.; Li, H.; Wilson, B. C. Photodynamic Molecular Beacon as an Activatable Photosensitizer Based on Protease-Controlled Singlet Oxygen Quenching and Activation Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 8989-8994 10.1073/pnas.0611142104
119. Liu, T. W.; Akens, M. K.; Chen, J.; Wise-Milestone, L.; Wilson, B. C.; Zheng, G. Imaging of Specific Activation of Photodynamic Molecular Beacons in Breast Cancer Vertebral Metastases Bioconjugate Chem. 2011, 22, 1021-1030 10.1021/bc200169x
120. Liu, T. W.; Akens, M. K.; Chen, J.; Wilson, B. C.; Zheng, G. Matrix Metalloproteinase-Based Photodynamic Molecular Beacons for Targeted Destruction of Bone Metastases in Vivo Photochem. Photobiol. Sci. 2016, 15, 375-381 10.1039/C5PP00414D
121. Yi, D. K.; Sun, I.; Ryu, J. H.; Koo, H.; Park, C. W.; Youn, I.; Choi, K.; Kwon, I. C.; Kim, K.; Ahn, C. Matrix Metalloproteinase Sensitive Gold Nanorod for Simultaneous Bioimaging and Photothermal Therapy of Cancer Bioconjugate Chem. 2010, 21, 2173-2177 10.1021/bc100308p
122. Yang, Y.; Aw, J.; Chen, K.; Liu, F.; Padmanabhan, P.; Hou, Y.; Cheng, Z.; Xing, B. Enzyme-Responsive Multifunctional Magnetic Nanoparticles for Tumor Intracellular Drug Delivery and Imaging Chem.-Asian J. 2011, 6, 1381-1389 10.1002/asia.201000905
123. Lock, L. L.; Tang, Z.; Keith, D.; Reyes, C.; Cui, H. Enzyme-Specific Doxorubicin Drug Beacon as Drug-Resistant Theranostic Molecular Probes ACS Macro Lett. 2015, 4, 552-555 10.1021/acsmacrolett.5b00170
124. Ansari, C.; Tikhomirov, G. A.; Hong, S. H.; Falconer, R. A.; Loadman, P. M.; Gill, J. H.; Castaneda, R.; Hazard, F. K.; Tong, L.; Lenkov, O. D.; Felsher, D. W.; Rao, J.; Daldrup-Link, H. E. Development of Novel Tumor-Targeted Theranostic Nanoparticles Activated by Membrane-Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance Imaging and Therapy Small 2014, 10, 566-575 10.1002/smll.201301456
125. Lee, G. Y.; Qian, W. P.; Wang, L.; Wang, Y. A.; Staley, C. a; Satpathy, M.; Nie, S.; Mao, H.; Yang, L. Theranostic Nanoparticles with Controlled Release of Gemcitabine for Targeted Therapy and MRI of Pancreatic Cancer ACS Nano 2013, 7, 2078-2089 10.1021/nn3043463